[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100558733":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":21,"centralContacts":25,"locations":20,"responsibleParty":30,"collaborators":20,"id":33,"slug":34,"hasResults":35,"nctId":36,"briefTitle":37,"officialTitle":38,"acronym":20,"eligibilityCriteria":39,"healthyVolunteers":40,"sex":41,"minAge":42,"maxAge":43,"enrollmentInfo":44,"targetDuration":20,"studyType":47,"phases":48,"briefSummary":50,"conditions":51,"keywords":20,"overallStatus":53,"whyStopped":20,"lastUpdateSubmitDate":54,"lastUpdatePostDateStruct":55,"startDateStruct":58,"completionDateStruct":60,"leadSponsor":62,"locationsCount":20},{"fullName":5,"class":6},"Assaf-Harofeh Medical Center","OTHER_GOV",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Patients undergoing laparoscopic salpingectomy for tubal ectopic pregnancy.","EXPERIMENTAL","Patient undergoing laparoscopic salpingectomy due to ectopic tubal pregnancy will be offered chromotubation as the same tome in order to asess the potency of the remaining fallopian tube. Data will be recorded.",[13],"Procedure: performing chromotubation during the laparoscopy in order to assess the tubal patency of the remaining fallopian tube",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"PROCEDURE","performing chromotubation during the laparoscopy in order to assess the tubal patency of the remaining fallopian tube","Performing chromotubation )injection of blue dye to the fallopian tube via cevical catheter) during the laparoscopy in order to assess the tubal patency of the remaining fallopian tube",[9],null,[22],{"name":23,"affiliation":5,"role":24},"Neta Eisenberg-Kogan, MD","PRINCIPAL_INVESTIGATOR",[26],{"name":23,"role":27,"phone":28,"phoneExt":20,"email":29},"CONTACT","+972542573878","netaeis3@gmail.com",{"type":24,"investigatorFullName":31,"investigatorTitle":32,"investigatorAffiliation":5,"oldNameTitle":20,"oldOrganization":20},"Neta Eisenberg Kogan","Attending physician in the gynecology endoscopy unit","100558733","chromotubation-on-the-remaining-fallopian-tube-after-a-laparoscopic-salpingectomy-due-to-tubal-pregnancy-100558733",false,"NCT06554964","Chromotubation on the Remaining Fallopian Tube After a Laparoscopic Salpingectomy Due to Tubal Pregnancy","Feasibility, Safety and Effectiveness of Chromotubation on the Remaining Fallopian Tube After a Laparoscopic Salpingectomy Due to Tubal Pregnancy","Inclusion Criteria:\n\nPatients undergoing laparoscopic salpingectomy for tubal ectopic pregnancy.\n\nExclusion Criteria:\n\n1. Patients with a history of unilateral salpingectomy\n2. Patients with suspected heterotopic pregnancy\n3. Patients with suspected allergic reaction to blue dye injection",true,"FEMALE","18 Years","50 Years",{"count":45,"type":46},100,"ESTIMATED","INTERVENTIONAL",[49],"NA","Ectopic pregnancy prevalence is approximately 1-2% of all pregnancies, majority of which located in the fallopian tube. Among the risk factors for ectopic pregnancy is tubal factor - meaning a mechanical problem within the fallopian tube resulting in the pregnancy remaining in the fallopian tube. The treatment o tubal pregnancy can be expectant, medical via metotrexate or surgicl via laparoscopic salpingectomy of the involved fallopian tube. The purpose of this study is to assess the feasibility of chromotubation during laparoscopic salpingectomy for the surgical management of tubal ectopic pregnancy hence assessing the function of the remaining fallopian tube and trying to predict future fertility for the patient.",[52],"Ectopic Pregnancy","NOT_YET_RECRUITING","2024-10-03",{"date":56,"type":57},"2024-10-08","ACTUAL",{"date":59,"type":46},"2024-09-30",{"date":61,"type":46},"2025-09-01",{"name":5,"class":6}]